James D. Bates
oral & maxillofacial surgery specialist
Key challenges facing global health care, including audiologic health care, relate to issues of access, equity, quality, and cost-effectiveness. In the past two decades, the world has seen exponential growth and development in Information Technologies that have revolutionized the way in which modern society communicates and exchanges information, and may provide a cost-effective and sustainable means of providing much-needed audiologic services to those populations identified as having restricted or limited access. These potential advantages of Tele-Health are particularly appealing in the field of global hearing health care where there is a dearth of hearing health professionals who are able to provide audiologic services to an increasing number of persons who require care. In addition to the prevalence of hearing loss and the shortage of hearing healthcare professionals, the advances in technology and rapid expansion in connectivity are opening up new avenues for delivering Tele-Audiology. The future of Tele-Audiology is likely to follow the trends in general technologic developments. One such area of current interest and rapid growth and development is mobile health (mHealth), relating to the use of mobile phone technologies to promote, provide, and monitor healthcare services. This field is particularly appealing with the widespread penetration of mobile phones and cellular network reception globally but particularly in underserved developing countries. This presentation aims at discussing recent advances in the field of Tele-Audiology.
DR Mostafa R Mohamed, Audio-vestibular medicine Consultant and Lecturer, Assiut University, Egypt. Dr Mohamed has been practicing in the field of audio-vestibular medicine since 1999, combining academic, Research, and clinical activities. Dr Mohamed is teaching post-graduate students. In addition, he has his clinic for assessing patients with Hearing loss, tinnitus and vestibular diseases. He is conducting both diagnostic and rehabilitative maneuvers , including acoustical and electrical sound amplification. Dr Mohamed has been practicing his field in Egypt, Germany, and Saudi Arabia. Main research interests of Dr Mohamed, was on Syndromic and non-Syndromic Genetic Hearing loss in Egyptian Population, with novel gene mutation discovery which was published in 2010.
for total rehabilitation; functionally and esthetically, of patients with post-cleftlip& palateclefcts ( uni-lateral and bilateral) in the age group 6 years to 18years. Study Design: Fifty patients (24 females, 26 males) with post-cleft palate defects, with a history of complete cleft lip, alveolus and palate,( 20 patients with bilateral and 30 patients with unilateral) who were treated in our center for (chelio-plasty and palato-plasty) . The study was conducted during the period between Jan. 2007 and Dec. 2011 years.
Professor Ahmed Mohamed Medra is professor in Department of Cranio-Maxillo-facial, Oral and Plastic Surgery, Faculty of Dentistry, at Alexandria University, Egypt. He is doubly qualified. He got the medical Degree (M.B.Ch.B, December 1977) .He holds Master Degree in General & Emergency Surgery, in January 1981, Faculty of Medicine Alexandria University. Then he got the Dental Degree,(BDS, Faculty of Dentistry, Alexandria University,1985. He got Doctorate in Cranio-Maxillofacial, Oral and Plastic Surgery,1987. He is the President of the Egyptian Society of Craniofacialmaxillofacial Surgeons, since 2009 till now(www.escmfs.com) and the president of the Egyptian Association of Cleft Lip& Palate and Craniofacal Anomalies ,from 2012 till now.
Author: Dr. Essam Hamed Amin Ali, Senior Quality Manager, Universal Hospital, Abu Dhabi, UAE Dr. Essam Hamed Amin Ali is a Professional with strong Quality Management and Hospital Management, planning and interpersonal skills possessing 26 years of rich experience in the health industry, experience in JCI with an established hospitals. He has completed his Doctorate Degree in Business Administration majoring in Quality Management, USA in 2007; MS in Quality Management System from the University of Wollongong, Australia in 2005 and Bachelor of Medicine from Cairo University, Cairo, Egypt in 1991. He is a Member of Medical Education Committee, Ministry of Health, UAE Abu Dhabi; he is a Team Leader in Sheikh Khalifa Excellence Award from 2002 till date; Team Leader in Abu Dhabi Award for Excellence in Government Performance – ADAEP and Lead Auditor for ISO 9001:2015. His areas of expertise include: Total Quality Management; ISO Standards; EFQM Model; JCI standard; Strategic Planning; Operations Management; Medical Staff Relations; Quality Assurance; Change Management; Cross Cultural Management; Continuous Quality Improvement; Trainer and Consultancy for Joint Commission International on Accreditation of Healthcare Organizations. Affiliation • Team Leader, Sheikh Khalifa Excellence Award from 2002 till date. • Department of Health as instructor for Emergency and Disaster Management • Team Leader Abu Dhabi Award for Excellence in Government Performance – ADAEP in the first season 2007 • Member of Medical Education Committee, Ministry of Health, UAE Abu Dhabi, from 2001 to 2006 • A member in the Board of Governance for Belvedere British School
Essam Hamed Amin Ali is a professional with strong quality management and hospital management, planning and interpersonal skills possessing 26 years of rich experience in the health industry, experience in JCI with established hospitals. He has completed his Doctorate degree in Business Administration majoring in Quality Management, USA in 2007; MS in Quality Management System from the University of Wollongong, Australia in 2005 and Bachelor of Medicine from Cairo University, Cairo, Egypt in 1991. He is a Member of Medical Education Committee, Ministry of Health, UAE. His areas of expertise include total quality management; ISO standards; EFQM model; JCI standard; Strategic planning; operations management; medical staff relations; quality assurance; change management; cross cultural management; continuous quality improvement; trainer and consultancy for joint commission international on accreditation of healthcare organizations.
With the current standards of care in management of head and neck oncology, the outcomes have been substantially stable over last few decades with overall survival for all stages not reaching beyond 50-60%. In recent years the focus has been shifted more to improve the quality of life of these patients. Oral cancer management involves surgery as a primary modality. Conventional techniques involve putting different skin incisions on face and neck to gain access and approach for radical clearance of the primary tumor and also the draining cervical nodes. Poor healing and wound dehiscence involves great risk of exposure of major neck vessels and facial disfigurement. Post-operative scars are especially noticeable in head and neck areas. The need for improved cosmetic outcomes has become increasingly emphasized. In recent years, advancements in minimally invasive techniques have allowed for better cosmetic outcomes without compromising oncological safety. Attention has been placed on smaller and more hidden incisions along with endoscopic and robotic assisted procedures. Robotic assisted procedures for thyroid, parathyroid tumors and neck lesions have been well described in literature. However major concern is cost, expertise and availability of the facility. Similar cosmetic results can be achieved with more cost effective techniques using endoscope. We share our experience of 20 endoscopic assisted head and neck procedures including neck dissection for head and neck cancer patients and thyroid surgery via retro-aural facelift approach from a single institute in India. The oncologic and cosmetic outcomes have been encouraging. We also suggest some modification in the standard described retro aural skin incision for the approach considering the anatomical difference in Indian population, the skin texture, hairline and length of neck.
Dr. Siddharth Shah is presently associated with Zydus Cancer Centre, Zydus Hospitals, Ahmedabad, Gujarat, India as a Consultant Head-Neck and Skull Base Surgeon. He did h is postgraduate in Otorhinolaryngology from BJ Medical College Ahmedabad in 2006. He received his extensive training in Head and Neck Oncology from premier apex cancer institute of India, Tata Memorial Hospital from 2006-2008. Later from same institute he did his fellowship in Skull Base Oncology between 2013 - 2014. He received his training in Robotics from Prof. Yoon Woo Koh, Severance Hospital, Seoul, South Korea in 2017. He has 12 years of clinical experience in management of Head and Neck Cancers. He has popularized the concept of enbloc compartmental resection for Infra Temporal Fossa Clearance in locally advanced (cT4b) oral cancers. He has pioneered the concept of minimal access surgeries in Head and Neck oncology in the state. He is the first in the state to start Endoscopic Assisted Thyroidectomy and Endoscopic Assisted Neck Dissection via Retro aural approach. His key areas of research interest is molecular margin assessment, oral cancer screening and efforts to improve overall survival.
AntigoniDelantoni, DDS, MSc, PhD, MD is an assistant Professor at the Aristotle University of Thessaloniki, where she serves as faculty. She is a graduate of the Aristotle University, School of Dentistry, Thessaloniki, Greece (1998). Her post degree training includes a 2-yr internship in Oral Radiology (University of British Columbia 2002) from where she got the MSc title in Oral Radiology and Diagnostics and a 2-yr continuing education program in oral implantology (Greek German Dental Association, 2009). In addition, she has completed a doctoral degree (Aristotle University School of Dentistry, Thessaloniki, Greece 2007) and has graduated from medical school (Aristotle University School of Medicine, Thessaloniki, Greece (2008) . She has also finished a postdoctoral research degree with a full scholarship by the Greek State Scholarships foundation (2009) and the first year of medical residency in radiology, having completed classical radiology and Ultrasonography training in the curriculum. She is a reviewer for over 30 international journals and member of the Editorial Board of several International publications. She has published numerous papers in greek and English and has participated as a speaker in a large number of congresses nationally and internationally covering a variety of topics with main focus on oral radiology and maxillofacial imaging.
dr. Gwendy Aniko is a Plastic Surgeon. dr. Gwendy Aniko Practices at Rumah Sakit Mitra Kemayoran in Kemayoran, Jakarta Pusat, and Rumah Sakit Mitra Keluarga Kelapa Gading in Kelapa Gading, Jakarta Utara. He received his education in Universitas Indonesia. He is a member of Ikatan Dokter Indonesia, and Perhimpunan Dokter Spesialis Orthopedi dan Traumatologi Indonesia. Services provided by the doctor are: Health Consultation, and Physical Examination.
The purpose of the current study was to examine patient’s perceptions of services for dysphagia therapy post radiation treatment for head and neck cancer. It is evident that Speech Pathology services are a necessary component during radiation, surgical, and or chemotherapy treatment for dysphagia (swallowing treatment). It is unique to explore current methods of therapy and success rate with patients post treatment. Patients with a diverse cultural and socioeconomic background with similar ages and diagnosis of head and neck cancer were selected in this process. The focus was on (a) amount of time since patient has eradicated cancer. (b) Necessary use of artificial source of nutrition/hydration. (c) Quality of life. A descriptive research process was employed in order to explain the patient’s perspectives of SLP’s treatment methodsin the above the mentioned issues. The participants in the present study resided in Naples Florida. A survey questionnaire based from MD Anderson’s Quality of LIfe was used to collect data for the present study.
Karen Moss completed her master’s at South Carolina State University and her undergraduate degree at the University of South Carolina, Columbia. Karen is an outpatient speech pathologist who specializes with swallowing and voice disorders, with a special interest in oral, head and neck cancer. She runs a support group for SPOHNC, (Support for people who have oral, head and neck cancer) and has been in avid practice for seventeen years.
Background: Mucormycosis is life threatening fungal infection that occurs in immunocompromised patient. .These infection is becoming increasingly common in yet survival remains very poor a great understanding of the pathogenesis of the disease may lead to future therapies. Material and methods: in present study we have made an attempt to evaluate a standard method of management of mucormycosis of nose and Para nasal sinuses .Total 30 cases of mucormycosis of nose and Para nasal sinuses were studied JIIUS IIMSR Warudi tq badnapur dist. Jalna a tertiary center from June 2014 to June 2017 thoroughly on the basis of clinical behavior, histopathological report and radiological investigation, we have tried to formulate a standard method of treatment in the form of medical and surgical debridement or combination in order to achieve the best possible results. Results: In this study male patient were 18[50%] cases and female were 12[40%] .Most common predisposing factor was diabetes mellitus in 24 [80%]cases and other factors were tuberculosis 4[13.33]and chronic renal failure 5[16.66].Most commonly presented age group was 4th decade to 5th decade 11[36.66]&8[26.66%] respectively. Most common symptom was nasal obstruction and sign was maxillary swelling 21[70%].Most common radiological finding was cloudiness of sinuses 27[90%] least common finding was intracranial extension 6[20%].Most common used treatment modalities was amphotericin B24[80%] and least used was surgical debridement by FESS 16[53%]. Conclusion: In the management of mucormycosis and its different pathological forms and most aggressive form like rhino cerebral mucormycosis prompt diagnosis based on clinical examination, reversal of predisposing condition and aggressive surgical debridement along with medical treatment remain corner stone of the therapy for this deadly disease
Dr. Sambhaji Govind Chintale is currently working as Associate Professor in ENT department at JIIUs Indian Institute of Medical Science & Research. He is a Senior Resident at Kem Hospital, Mumbai from 1st Feb to 31st Jul 2012 and Senior Resident at DR. R N Cooper Hospital, Mumbai from 15th Sep to 15th Jan 2013. He has published many papers in reputed journals like Indian Journal of Basic and Applied Medical Research, Otolaryngology Online journal, and International Journal of Recent Trend in Science and Technology.
ZENKER pharyngeal pouch, is a condition characterized by ’S DIVERTICULUM (ZD), also known as herniation of the posterior pharyngeal wall. Specifically, this occurs in an area located between the thyropharyngeus and the cricopharyngeal muscle fibers of the inferior constrictor, known as Killian’s triangle.1 ZD is a relatively rare disorder with a prevalence ranging between 0.01% and 0.11%.2 There is a male preponderance and it is most common in the 7th–8th decades of life.3 Clinically, ZD may manifest with symptoms such as dysphagia, regurgitation, and its associated complications. Historically, ZD was first described in 1769 by Ludlow,4 an English surgeon, as an autopsy finding. In 1877, Zenker described an esophageal diverticulum occurring as a result of ‘forces with the lumen acting against restriction’ and the condition has since been eponymized.5 In 1886, Wheeler carried out the first surgical excision of ZD.6 Endoscopic treatment for ZD was introduced by Mosher in 19177 who excised the diverticular septum using a rigid endoscope. This was modified by Dohlman and Mattsson in 1960 who incorporated the use of diathermy.8 In 1993, the technique further evolved to include endoscopic stapling after septal division.9 As ZD commonly affects the elderly, there has been increasing demand for minimally invasive methods for the population who may otherwise have been unsuitable for general anesthesia. The first use of minimally invasive flexible endoscopic therapy in ZD was reported in 1995 by Mulder and Ishioka.10,11 Ever since, endoscopic techniques have been adapted over the last two decades with increasing operative success and safety profile, and are beginning to replace conventional surgery as the mainstay of treatment for ZD. The present review aims to provide a synopsis of the established and emerging therapeutic methods for ZD, with particular focus on the latest evidence.
Professor Ishaq received his specialist training in Scotland, North East and West Midland and has worked at major teaching centres in the Birmingham, Newcastle upon Tyne, Aberdeen and Stoke on Trent. He is an experienced Gastroenterologist, interventional endoscopist and bowel cancer screener. He is the first one to introduce endoscopic treatment of Zenker in UK. He has participated in many live international endoscopy workshops and invited as speaker to many international Gastroenterology society meeting. He is reviewer to may peer reviewed journal and is on editorial committee of GHBB. He has worked on project with NICE and NCEPOD.
This descriptive prospective study, (non – controlled clinical trial) was conducted during period of February 2016 to February 2017 in AL-Jadryia private hospital total of 80 patients age range (8 – 64 years old) Gender distribution was 55% male, 45 % female. The patients where compelling from Tonsil hyperplasia, Chronic tonsillitis, Recurrent acute tonsillitis not responding to medical treatment. Surgical Ultrasound (Intra-capsular tonsillotomy) technique was done to them under L.A Aim of study: 1- To evaluated subjective & Objective improvement of using ultra sound volumetric tissue reduction technique (intra-capsular Tonsillotomy) in patient with Chronic Tonsillitis & Tonsillar Hyperplasia. 2- Evaluated of safety and effectiveness of surgical ultra sound in management of Chronic Tonsillitis and Tonsillar Hyperplasia. Patient and methods: The patients where compelling from Tonsil hyperplasia, Chronic tonsillitis, Recurrent acute tonsillitis not responding to medical treatment. Surgical Ultrasound tonsilletomy technique was done to them under L.A, The patient was placed in semi sitting position Use of 10% xylocaine spray as regional anesthesia for 7 minute. Ultrasound generator until adjusted 44 – 55 intensity. The probe was introduced through tonsillar crypt while the a devise is activated , probe introduce for few second until the shrinkage has been occurred before leaving out probe , circular movement on entry point to ensure good hemostasis for few second (5–10 sec.) 4–6 entrance in different site of tonsil may applied according to the size and the shrinkage that had been occurred(A phenomenon known as cavitations). Results: There is minimal to no bleeding and pain , Slough can be seen in the first week after that disappear ,slight shrinkage in the size immediate (intra-operation) but can be seen obvious after 6 weeks, there is subjective improvement in the snoring as per patient partners. Conclusions: The results suggests that surgical Ultrasound tonsillectomy technique is an efficient & well tolerated procedure for the management of chronic tonsillitis and tonsillar hyperplasia.
Adnan Qahtan Khalaf was born in Baghdad 1974, done M.B.Ch.B in year 1999 from Baghdad Medical College. He was specialized with otolaryngology in year 2010 from Iraqi Board of medical and completed High diploma (Laser in medicine) From Institute of Laser /Baghdad University 2012. Now working in AL-Yarmouk teaching hospitals in Baghdad as ENT & Laser specialist.
Adam Frosh FRCS, Carina Cruz MRES, Thomas Samuel FRCA Lister Hospital, Stevenage, SG1 4AB, UK Neuropathic and migrainous forms of face pain including atypical face pain and trigeminal nerve neuralgia are often associated with significant loss of quality of life for the sufferer. They are often unresponsive to conventional treatments such as anticonvulsants and tricyclic antidepressants, which are often poorly tolerated and can cause significant side-effects. Although SPGB has been shown to be a safe and effective treatment for these conditions, it has failed to gain popularity largely because access to the ganglion is anatomically difficult. We present a novel technique where submucosal injection of 1 ml of 1% lidocaine and depomedrone 40 mg is injected submucosally over the superior part of the vertical plate of palatine bone via a trans-nasal approach. This is performed under direct vision using a rigid nasal endoscope under a 10-minute general anesthetic as a day case procedure. We present a case series of 26 patients (13 female, 13 male) with forms of face pain resistant to conventional treatment, who have undergone our technique of SPGB. The outcomes were: 7 reported they were rendered asymptomatic of pain, 6 reported their pain had improved and 13 were symptomatically unchanged. We feel that given the selection of patients included highly resistant, long-standing symptoms of face pain, that a significant improvement in 50% of the subjects would indicate this technique to be a serious consideration for the treatment for future patients. The technique is straightforward and can easily be delivered by an otolaryngologist familiar with the basic techniques of endoscopic sinus surgery.
Adam Frosh is a consultant otolaryngologist at the Lister Hospital, Stevenage, UK, an Honorary Senior Lecturer at the University of Hertfordshire, UK and an Honorary Research Fellow at the MRC Institute of Prion Diseases. Carina Cruz a senior research nurse and Thomas Samuel a consultant in Anesthesiology and chronic pain management at the Lister Hospital.
Length of Presentation:2.0 Hours Type of Presentation: PowerPoint lecture&participant discussion Instructor: Max Stanley Chartrand, Ph.D., CSP, (Behavioral Medicine), Managing Director/DigiCare Behavioral Research Objective: To deepen attendees' knowledge and skills in Case History, Video Otoscopy Biomarkers (FDA Red Flags & other otorelated conditions), Referral, and considerations in correcting permanent hearing impairment. Learning Outcomes: 1) Define video otoscopy biomarkers as they relate to the FDA Eight Red Flags. 2) Describe EAC mechanoreceptors and other features of EAC physiology as they relate to hearing instrument fitting tasks. 3) Observe ototoxicity and changes in health demographics of the hearing impaired population. 4) To differentiate ear conditions and abnormalities for disposition to fit or refer. 5) To apply principles of video otoscopy and ear physiology more effectively in audiology and otology practice. The 1978 FDA Hearing Aid Rule, with the 8 Red Flag Conditions, brought well defined biomarkers into audiology and otolaryngology. Subsequent advances in otoscopy, and later in video otoscopy, brought greater clarity and the potential for greater differentiation into the allied professions that comprised the community hearing healthcare team. Audiologists’ training in the best practice standards in utilizing video otoscopy, along with education in external ear acoustics, neurophysiology, prosthetic couplers, and psychoacoustics has become essential for these advancements to optimally benefit hearing impaired consumers. While statistically only about 13% of hearing impaired individuals will require medical referral before being fitted with a hearing aid, there is a sizable and growing number of those whose subclinical idiosyncrasies require special consideration in the evaluation and fitting process. Among hearing impaired individuals who experience potential fitting challenges are the rapidly growing number of those who suffer with co-morbid conditions of diabetes mellitus type 2, cardiovascular, inflammatory chronic conditions, and auto-immune diseases. This course is designed to bring recent discoveries in ear neurophysiology, advancements in otoprosthetics and video otoscopy, and the application of this knowledge these issues and developments to the attention of the community hearing health care team for greater success in meeting the needs of the hearing impaired population. Course Outline I. Introduction- A. What are biomarkers? (Defined by NIH) B. Review of 1978 FDA Red and subsequent updates II. Public health trends affecting dispensing practice A. Rapid rise in acidosis-related & ototoxicity conditions B. New causal factors in hearing loss & tinnitus III. External Auditory Canal Physiology & Neurophysiology A. Keratin growth and abnormalities B. EAC mechanoreceptors & reflexes C. Differentiation: Impacted cerumen, keratosis obturans, external ear cholesteatoma E. Relate to Case History Notes/Patient Reports F. Impression/earmold considerations G. Referral and fitting considerations IV. Presented Case Histories: Q&A
Dr. Max Stanley Chartrand, Ph.D., BC-HIS, CSP is a professional educator, widely published author, and professor of Behavioral Medicine. He serves on the Council for Nutritional & Environmental Medicine and serves on the Federal & State Advocacy Committee of the International Hearing Society, and the state advisory committee for Speech Pathologists, Audiologists, and Hearing Aid Providers in his home state. He is also a past Advisory Board Member of the American Tinnitus Association and Better Hearing Institute, and promotes the advancement of education and professional skills for all the hearing health professions, and for hearing impaired consumers. He believes the key for serving more hearing impaired individuals is through educating them about the true consequences of uncorrected hearing loss and the wonderful solutions available to them through the world’s best hearing health delivery system.
Sleep-disordered breathing is a hot topic in dentistry and medicine today. Dentists are in a unique position to screen for, diagnose and treat their patients with obstructive sleep apnea. OSA is a serious, potentially life-threatening condition which can result in hypertension, congestive heart failure and even death. This presentation will cover the screening, diagnosis and contemporary management of sleep-disordered breathing in a comprehensive format, both for the general restorative dentist, the orthodontist and the oral and maxillofacial surgical specialists. From the medical history and clinical examination, to radiographic and diagnostic imaging findings, to a detailed discussion of the clinical polysomnogram and sleep medicine consultation referral, to mandibular advancement oral appliance therapy and CPAP therapy, to upper airway surgery including uvulopalatopharyngoplasty (UPPP), laser-assisted uvuloplasty (LAUP), nasal septoplasty, inferior turbinectomy, tonsillectomy and adenoidectomy, radiofrequency tongue and soft palate ablation, to maxillomandibular advancement and genioglossus advancement, to tongue and hyoid suspension, this presentation will provide direct and practical real life ways to improve the health and prolong the life of your patients with maximal fulfillment in return.
James D. Bates, D.D.S., M.D., is an American board-certified oral and maxillofacial surgeon in active private practice in Dallas, Texas. Originally from Lubbock, Texas, he attended Texas Tech University as an undergraduate. He graduated with many honors from The University of Texas Dental Branch at Houston with a D.D.S. degree, and from Texas Tech University School of Medicine with an M.D. degree. In addition, he completed an internship in general surgery at Baylor University Medical Center, and completed an accredited residency in oral and maxillofacial surgery at The University of Texas Health Science Center in Houston. As a parttime faculty member at Texas A&M Baylor College of Dentistry in the Department of Oral and Maxillofacial Surgery, he taught physical examination and internal medicine to graduate students in all specialties as a Clinical Associate Professor for 18 years. As the founder of Texas Oral and Maxillofacial Surgery, his practice is proud to have maintained 12 years of continuous accreditation as an Office-Based Surgery Practice by the internationally-recognized Joint Commission. His practice focuses on providing full-scope oral and maxillofacial surgery services including orthognathic and TMJ surgery.
Labyrinthinefistulaemay have differentetiologies : congenital malformation, post infectious, post traumatic and idiopathic. In the litteraturewefinddifferentresultsaftersurgery and thereisreally no consensus regarding the approach of labyrinthinefistulae. The decision for surgeryisoften case per case. Our serieincludesthirty five patients with a surgeryfor an exploration of the middle ear for suspicion of fistula : twentywithtraumatichistory and fifteenwith none traumatichistory. Weanalysedtheresultsofdifferentexaminations: complaintsofthepatients, audiometry, imagerybycttoscanand/orby MRI , vestibular balancesheetincludingcandovempsandper-operativediscoveries. Allthatwascorrelatedwith theresultsin immediatepostsurgical situation,oneyearandtwoyearsaftersurgery. Findingsmay help the surgeon to take the decision for a surgical exploration of the middle ear.
i will upload
Occupational noise-induced hearing loss (ONIHL) describes an acquired hearing impairment attributable to excessive workplace noise exposure. ONIHL is likely to contribute to a very high proportion of the cases of hearing loss in adults. In Italy noise deafness affects almost two thirds of fishermen. the motorists and theCommanders present a greater risk of developing noise-induced hearing loss compared tosailors. These data are in agreement with those reported in studies conducted in other countries. The main source of noise insideof the boats is represented by the engines that produce high sound levels tooin fishing vessels of less than 30 m in length. A further aspect related to noise on fishing vessels is represented by exposuresometimes continuous; it is estimated that a 24-hour exposure at 85 dB (A) matchesat an exposure of 8 hours to 90 dB (A). The high and constant exposure to noise, even during the few hours of rest on board, helps to develop not only the hearing loss but also sleep disorders and alterations of blood pressure and favors the occurrence of injuries.On the boat, the exposure time cannot be reduced, but the researchers recommend that measures are taken to decrease the intensity of the noise. Besides, they ask to the workers to receive a training and ormation on the hearing health and on the raising awareness and sensitization to the noise exposure, to take regularly hearing tests and to be followed in the long term to warnthe risks of the deafness further to the noise.
Dr. Lucio Maci did his Diploma in High School Calasanzio of Campi Salentina (LE) Later his Bachelor’s Degree in Medicine and Surgery at the University of Padua. After completion of Bachelor’s he did Master’s Specialization in Otorhinolaryngology in the same University with the score 70/70 and praise. After his Master’s he worked as Consultant O.R.L. Centres Medico-Legal I.N.A.I.L. Brindisi and Lecce. Later he worked at Consultant O.R.L. A.S.L.LE/1. In his professional career he attended as Speaker at 12 National Congresses and 1 in France. Due to his enthusiastic nature and interest in research has authored and published numerous articles devoted mostly to accidents and occupational diseases to the district ORL.
ABSTRACT: RADIOFREQUENCY IS HIGH FREQUENCY ALTERNATING CURRENT USED IN ABLATIVE TREATMENT OF TONGUE BASE, PALATE, TONSIL AND NASAL TURBINATES IN OBSTRUCTIVE SLEEP APNOEA. IT ENTAILS GIVING OF HIGH FREQUENCY ENERGY TO THESE STRUCTURES CAUSING ABLATION, INFLAMMATION AND SUBSEQUENT HEALING WITH FIBROSIS. RADIOFREQUENCY HAS MANY APPLICATIONS IN ENT, BUT THE MAIN ARE FOR OBSTRUCTIVE SLEEP APNOEA.WE WOULD LIKE TO DISCUSS OUR ATTEMPTS AT APPLYING RADIOFREQUENCY (RF) TO VARIOUSANATOMICAL STRUCTURES. APPLICATIONS OF RF ON PALATE, TONGUE BASE, NASAL TURBINATES AND TONSILS ARE MENTIONED. IMAGE PUBLICATlON–RF PRINCIPLE FOR SNORING SLEEP APNOEA
Neha shah HAS been a practicingprivate ENT consultant in south MumbaiIndia since more than a decade. She has passed out from the prestigious Topiwalla National medical college securing first rank at several examinations. She has further added to her academics by giving the plab and partly covering the DOHNS and MRCS examinations.She has done several fellowships from Singapore in snoring sleep apnoea. She has had a clinical attachment of upto four monthsin snoring obstructive sleep apnoea at RNTNE hospital London. She has been a general ENT surgeon with special interest in snoring sleep apnoeawork,done with sutter radiofrequency unit BM 780 model. It included radiofrequency ablative procedures for obstructive sleep apnoeaas well as for other general ENT surgeries.